Arafat, A.M.A., Botros, S.K.A., Afifi, R., Zayed, S.A. and Fateen, M. 2022. Serum Level of High-Mobility Group Box Protein 1 as a Potential Treatment Target in Egyptian Sickle Cell Disease Patients. Open Access Macedonian Journal of Medical Sciences. 10, B (Apr. 2022), 1072–1078. DOI:https://doi.org/10.3889/oamjms.2022.8868.